Better Coronavirus Vaccine Stock: BioNTech vs. Moderna

Better Coronavirus Vaccine Stock: BioNTech vs. Moderna

There are now 23 coronavirus vaccine candidates in clinical testing, according to the World Health Organization. BioNTech (NASDAQ: BNTX) and Moderna (NASDAQ: MRNA) developed two of those four mRNA COVID-19 vaccine candidates. Probably the most important reason why investors might prefer BioNTech over Moderna is the difference between their respective valuations.